Clinical Applications of CBD, THC and Cannabis Derived Therapies for Age Management Medicine – Full Course
Evaluation Summary
0 of 21 Questions completed
Questions:
Information
You have already completed the evaluation before. Hence you can not start it again.
Evaluation is loading…
You must sign in or sign up to start the evaluation.
You must first complete the following:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 21
1. Question
What influenced you to participate in this CME activity?
-
Question 2 of 21
2. Question
If “Other” please specify
-
This response will be awarded full points automatically, but it can be reviewed and adjusted after submission.
-
-
Question 3 of 21
3. Question
Prior to attending this event how competent were you in treating patients related to the use of Cannabis and CBD for Age Management?
-
Question 4 of 21
4. Question
At the conclusion of this series of lectures, how competent do you now feel treating patients with a variety of conditions using CBD and Cannabis?
-
Question 5 of 21
5. Question
Overall Impression of the Webinar Series on Clinical Applications for CBD, THC and Cannabis Derived Therapies for Age Management Medicine
-
Question 6 of 21
6. Question
Program Comments
-
This response will be awarded full points automatically, but it can be reviewed and adjusted after submission.
-
-
Question 7 of 21
7. Question
Did you perceive the presence of commercial bias in the CBD and Cannabis Track?
-
Question 8 of 21
8. Question
If you selected ‘Yes’ above, please explain
-
This response will be awarded full points automatically, but it can be reviewed and adjusted after submission.
-
-
Question 9 of 21
9. Question
Please rate the lecture “Scientific Rationale for the Use of Marijuana, CBD, and other Derivatives for Use as Clinical Applications”
-
Question 10 of 21
10. Question
Please rate the lecture: “Role of DEA and FDA in Use of CBD and THC”
-
Question 11 of 21
11. Question
Please rate the lecture “Alzheimer’s Disease/Dementia and Cannabinoids—Is It an Option?”
-
Question 12 of 21
12. Question
Please rate the lecture “CBD for Autoimmune and Inflammatory Diseases”
-
Question 13 of 21
13. Question
Please rate the lecture “The Endocannabinoid System and Unique Female Issues”
-
Question 14 of 21
14. Question
Please rate the lecture “CBD and THC as a Treatment for Neurological Disease”
-
Question 15 of 21
15. Question
Please rate the lecture “Full Spectrum Cannabis: Benefits Beyond THC and CBD”
-
Question 16 of 21
16. Question
Please rate the lecture “Clinical Practice and Practice Guidelines fo the Use of Medical Marijuana”
-
Question 17 of 21
17. Question
Please rate the lecture “Proper Dosages of Cannabis”
-
Question 18 of 21
18. Question
Please rate the lecture “How Cannabis Battles the So-Called Opiate Epidemic”
-
Question 19 of 21
19. Question
Please rate the educational content presented
-
Question 20 of 21
20. Question
To what extent do you feel that your participation in this activity has improved your knowledge/understanding of this topic? Please rate 1= Least Improvement, 5= Most Improvement
-
Question 21 of 21
21. Question
To what extent do you feel that your participation in this activity will improve your abilities, with respect to skills described during this program? 1= Least Improvement, 5= Most Improvement